Xiong et al., 1984 - Google Patents
Detection in vivo of a new gene product (gene III) of cauliflower mosaic virusXiong et al., 1984
View PDF- Document ID
- 7447030527663500374
- Author
- Xiong C
- Lebeurier G
- Hirth L
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
Cauliflower mosaic virus DNA contains six major open reading frames (ORFs). As only the mRNA corresponding to the transcription of gene VI and its translation product have been isolated, the identification in infected plants of products corresponding to the five other …
- 241000701489 Cauliflower mosaic virus 0 title abstract description 13
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tam et al. | Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T-and B-cell epitopes. | |
Emini et al. | Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides | |
Xiong et al. | Detection in vivo of a new gene product (gene III) of cauliflower mosaic virus | |
Oppermann et al. | A joint product of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase | |
Takeya et al. | DNA sequence of the viral and cellular src gene of chickens. 1. Complete nucleotide sequence of an EcoRI fragment of recovered avian sarcoma virus which codes for gp37 and pp60src | |
Lerner | Tapping the immunological repertoire to produce antibodies of predetermined specificity | |
Baron et al. | Antibodies against the chemically synthesized genome-linked protein of poliovirus react with native virus-specific proteins | |
KR100291247B1 (en) | Peptide and Nucleic Acid Sequences Associated with Epstein Barr Virus | |
US4708871A (en) | Antigenically active amino acid sequences | |
JP4444372B2 (en) | Viral substances and nucleotide fragments involved in multiple sclerosis for diagnosis, prevention and treatment | |
Walter et al. | Antibodies against synthetic peptides | |
Buchmeier et al. | Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection | |
Walter et al. | Antibodies specific for the polyoma virus middle-size tumor antigen. | |
Greenspan et al. | Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells | |
Xiong et al. | Identification by immunoprecipitation of cauliflower mosaic virus in vitro major translation product with a specific serum against viroplasm protein | |
McLean et al. | Generation of anti-peptide and anti-protein sera Effect of peptide presentation on immunogenicity | |
Harvey et al. | An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites | |
Michael et al. | All eight unassigned reading frames of mouse mitochondrial DNA are expressed. | |
Zauner et al. | Identification of the polypeptide encoded by the URF‐1 gene of Neurospora crassa mtDNA | |
Ooshika et al. | Identification of the 30K protein of TMV by immunoprecipitation with antibodies directed against a synthetic peptide | |
Baron et al. | Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro | |
JP2002506419A (en) | Antigen-reactive region of hepatitis A virus polyprotein | |
CA2178057C (en) | Epstein-barr virus peptides and antibodies against these peptides | |
AU2638295A (en) | Compositions of transactivating proteins of human immunodeficiency virus | |
Raychaudhuri et al. | Heterogeneous nuclear ribonucleoprotein complexes and proteins in Drosophila melanogaster |